Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Buller

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Oncogene|December 5, 1996
Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reactionA K Sood, R E Buller
Gynecologic Oncology|July 1, 1994
Lactobacillus sepsis with pelvic abscessJ P Connor, R E Buller
Molecular Genetics and Metabolism|August 28, 1998
Optimization of PCR and electrophoresis conditions enhances mutation analysis of the BRCA1 geneT A Lallas, R E Buller
American Journal of Obstetrics and Gynecology|August 15, 1980
The treatment of cervical intraepithelial neoplasia by cone biopsyH W Jones, R E Buller
American Journal of Obstetrics and Gynecology|April 1, 1996
CA 125 kinetics: a cost-effective clinical tool to evaluate clinical trial outcomes in the 1990sR E Buller, S Vasilev, P J DiSaia
Gynecologic Oncology|July 1, 1994
Effects of GnRH analogs on six ovarian cancer cell lines in cultureJ P Connor, R E Buller, P M Conn
European Journal of Gynaecological Oncology|May 8, 2008
Tunneled central venous catheters in a gynecologic oncology service: operative and short-term complicationsJ P Geisler, R E Buller, K J Manahan
Obstetrics and Gynecology|May 1, 1990
Indiana pouch continent urinary reservoir in patients with previous pelvic irradiationR S Mannel, P S Braly, R E Buller
Methods in Enzymology|January 1, 1975
Steroid hormone-receptor interactions with nuclear constituentsW T Schrader, S H Socher, R E Buller
Gynecologic Oncology|February 24, 2000
Xp22.2-3 loss of heterozygosity is associated with germline BRCA1 mutation in ovarian cancerT E Buekers, T A Lallas, R E Buller
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Oncogene|December 5, 1996
Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reactionA K Sood, R E Buller
Gynecologic Oncology|July 1, 1994
Lactobacillus sepsis with pelvic abscessJ P Connor, R E Buller
Molecular Genetics and Metabolism|August 28, 1998
Optimization of PCR and electrophoresis conditions enhances mutation analysis of the BRCA1 geneT A Lallas, R E Buller
American Journal of Obstetrics and Gynecology|August 15, 1980
The treatment of cervical intraepithelial neoplasia by cone biopsyH W Jones, R E Buller
American Journal of Obstetrics and Gynecology|April 1, 1996
CA 125 kinetics: a cost-effective clinical tool to evaluate clinical trial outcomes in the 1990sR E Buller, S Vasilev, P J DiSaia
Gynecologic Oncology|July 1, 1994
Effects of GnRH analogs on six ovarian cancer cell lines in cultureJ P Connor, R E Buller, P M Conn
European Journal of Gynaecological Oncology|May 8, 2008
Tunneled central venous catheters in a gynecologic oncology service: operative and short-term complicationsJ P Geisler, R E Buller, K J Manahan
Obstetrics and Gynecology|May 1, 1990
Indiana pouch continent urinary reservoir in patients with previous pelvic irradiationR S Mannel, P S Braly, R E Buller
Methods in Enzymology|January 1, 1975
Steroid hormone-receptor interactions with nuclear constituentsW T Schrader, S H Socher, R E Buller
Gynecologic Oncology|February 24, 2000
Xp22.2-3 loss of heterozygosity is associated with germline BRCA1 mutation in ovarian cancerT E Buekers, T A Lallas, R E Buller
Pageof 10